跳至主要内容
临床试验/NCT07381816
NCT07381816Enrolling By Invitation不适用

GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
30
试验地点
1
主要终点
Blood flow

研究概览

简要总结

This project will describe the mechanisms of action and the relative contributions of GIP to changes in gastrointestinal blood flow induced by oral glucose and endogenous GIP with the use of a receptor antagonists GIP(3-30)NH2 in patients with postprandial hypotension.

详细描述

Each participant will attend three independent randomised experimental days in the MRI-scanner with intravenous infusion (hormone/placebo) and oral ingestion (glucose): An intravenous infusion of saline or GIP(3-30)NH2 starts at time point -20 minutes.The infusions are combined with an oral glucose tolerance test (75 gram of glucose dissolved in 250 ml water ingested orally) at time point 0 minutes on two of the experimental days (with and without GIP(3-30)NH2). Furthermore one day will be with handgrip exercise, without an infusion. Therefore the first two days are in randomized order.

MRI measurements are repeatedly performed and blood samples are drawn to be analysed for endocrine responses from the intestines and pancreas.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For the PPH group
  • Inclusion Criteria:
  • Postprandial hypotension
  • Symptoms of postprandial hypotension

排除标准

  • Treatment with drugs that cannot be paused for 12 hours
  • Metallic implants that does not tolerate MRI
  • Any other disease or dysfunction that may disturb blood flow to the gut
  • Intake of more than 14 units of alcohol per week or abuse of drugs
  • Blood vessels that are not feasible for measuring flow in the MRI scanner
  • Low blood percent
  • Decreased kidney function
  • Decreased liver function
  • Claustrophobia
  • For the healthy group
  • Inclusion Criteria:
  • Matched by age, gender and BMI
  • Exclusion Criteria:
  • Postprandial hypotension
  • Metallic implants that does not tolerate MRI
  • Intake of more than 14 units of alcohol per week or abuse of drugs
  • Blood vessels that are not feasible for measuring flow in the MRI scanner
  • Low blood percent
  • Decreased kidney function
  • Decreased liver function
  • Claustrophobia
  • Autonomic dysfunction or other disease that cause changes in blood pressure during or after a meal
  • Intake of pharmaceutical products that influence the blood pressure

研究组 & 干预措施

Postprandial hypotension group

Experimental

MRI scans of PPH patients. 3 interventions

干预措施: MRI + GIPR antagonist (Tool) (Other)

Postprandial hypotension group

Experimental

MRI scans of PPH patients. 3 interventions

干预措施: MRI + hangrip (Other)

Postprandial hypotension group

Experimental

MRI scans of PPH patients. 3 interventions

干预措施: Saline and oral glucose (Other)

Healthy matched controls

Placebo Comparator

MRI scans of healthy controls. Crossover design three interventions.

干预措施: MRI + GIPR antagonist (Tool) (Other)

Healthy matched controls

Placebo Comparator

MRI scans of healthy controls. Crossover design three interventions.

干预措施: MRI + hangrip (Other)

Healthy matched controls

Placebo Comparator

MRI scans of healthy controls. Crossover design three interventions.

干预措施: Saline and oral glucose (Other)

结局指标

主要结局

Blood flow

时间窗: 145 minutes

Redistribution of splanchnic blood flow in the vessel mesenteric superior artery. Measured with functional MRI in ml/min

次要结局

  • Blood flow(145 minutes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验